Lv2
140 积分 2022-05-19 加入
Potential drugs for reducing the occurrence of immune checkpoint inhibitor-induced interstitial lung disease: an exploratory study using the JADER and FAERS databases
19天前
已完结
Possible clinical drug interactions between ticagrelor and concomitant medications: for adverse drug event monitoring in real-world
19天前
已完结
Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung Cancer
1个月前
已完结
Post-marketing Safety Evaluation of Lutathera ( 177 Lu-DOTATATE) : A Pharmacovigilance Analysis of FDA Adverse Event Reporting System
4个月前
已完结
Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study
4个月前
已完结
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
5个月前
已完结
Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy
5个月前
已完结
Primary Suspect Drugs of Cataracts in Pediatric Patients: An FDA Adverse Events Reporting Database Analysis
8个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
9个月前
已完结
Association of Anti-VEGF Therapy with Reported Ocular Adverse Events: A Global Pharmacovigilance Analysis
9个月前
已关闭
皖公网安备34019202002308
